| ALL | acute lymphocytic leukemia |
| AML | acute myelogenous (myeloid) leukemia |
| APL | acute promyelocytic leukemia |
| ATO | arsenic trioxide |
| ATRA | all-trans retinoic acid |
| CDK | cyclin-dependent kinase |
| CML | chronic myelogenous (myeloid) leukemia |
| CTD | carboxy-terminal domain |
| HSC | hematopoietic stem cell |
| HAT | histone acetyltransferases |
| HDAC | histone deacetylase |
| HMT | histone methyltransferase |
| LSC | leukemia stem cell |
| MDS | myelodysplastic syndrome |
| MLL-r | MLL rearrangements |
| MPN | myeloproliferative neoplasm |
| NBs | nuclear bodies |
| Ph | Philadelphia chromosome |
| PROTACs | proteolysis-targeting chimeras |
| RNA Pol II | RNA polymerase II |
| SE | super-enhancer |
| TF | transcription factor |
| UPS | ubiquitin/proteasome system |